Human Genome Sciences Inc. (HGSI)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 13.61
   
  • Change Today:
    $-0.01
  • 52 Week High: $27.37
  • 52 Week Low: $6.64
  • Currency: US Dollars
  • Shares Issued: 199.37m
  • Volume: 2,868,244
  • Market Cap: $2,713.41m
  • RiskGrade: 649
  • Beta: 0.95

HGSI Overview

1 Day Chart (25-05-2012)

1 Day Chart

6 Month Chart

6 Month Chart

HGSI Fundamentals

Fundamentals data is not available for this company.

HGSI Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 227.08 (294.35) (148.44)¢ n/a n/a n/a n/a 0.0%
31-Dec-13 381.37 (200.55) (97.96)¢ n/a n/a n/a n/a 0.0%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

HGSI ShareCast News

Glaxo goes hostile in HGS takeover 09-May-2012 ShareCast
US close: Stocks down second day running 19-Apr-2012 ShareCast
Glaxo sees offer rejected by Human Genome Sciences 19-Apr-2012 ShareCast

HGSI Top Newspaper Links

Lupus Drug Shows Promise in New Trial 03-Nov-2009 New York Times
HGS Stock Up 277% On Lupus Results 21-Jul-2009 Washington Post
Local Briefing 11-Mar-2009 Washington Post

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HGSI Market Data

Currency US Dollars
Share Price $ 13.61
Change Today $ -0.01
% Change -0.07 %
52 Week High $27.37
52 Week Low $6.64
Volume 2,868,244
Shares Issued 199.37m
Market Cap $2,713.41m
Beta 0.95
RiskGrade 649

What The Brokers Say

Strong Buy 6
Buy 1
Neutral 12
Sell 0
Strong Sell 0
Total 19
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:00 8,692 @ $13.61
16:00 200 @ $13.61
15:59 100 @ $13.61
15:59 100 @ $13.61
15:59 100 @ $13.61

Top of Page